Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort

Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial

“… 36 A similar cohort study showed that health care resource utilization and medical costs in patients with CKD were substantially high early in the disease continuum and increased in line with CKD progression. 37 Thus, improvements in KDIGO risk category may potentially reduce the associated health care costs in this patient population.…”

Economic Burden of the Stages of Pediatric CKD on the US Healthcare System

“…2 It is clear that the high cost of CKD is a global phenomenon that needs to be addressed. [9][10][11][12][13][14][15][16][17][18]…”

Cardiovascular-Kidney-Metabolic Health Syndrome

“…Earlier detection and screening for CKD using both eGFR and UACR in individuals at even low or moderate risk may substantially delay or prevent progression of CKD, increase life-years and quality of life, and reduce health care costs. 4,5…”

“…Earlier detection and screening for CKD using both eGFR and UACR in individuals at even low or moderate risk may substantially delay or prevent progression of CKD, increase life-years and quality of life, and reduce health care costs. 4,5 Kidney Disease across the Lifespan Kidney disease is not just a disease affecting older adults. As the incidence of metabolic diseases and obesity increases in younger individuals and children, greater guidance is needed on how and when to screen for complications such as CKD.…”